Barclays’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $6 | Hold |
|
|||||
|
2022
Q3 | $0 | Hold |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $43K | Buy |
|
|||||
|
2021
Q4 | $78K | Sell |
|
|||||
|
2021
Q3 | $101K | Sell |
|
|||||
|
2021
Q2 | $126K | Buy |
|
|||||
|
2021
Q1 | $45K | Buy |
|
|||||
|
2020
Q4 | $16K | Sell |
|
|||||
|
2020
Q3 | $36K | Sell |
|
|||||
|
2020
Q2 | $80K | Buy |
|
|||||
|
2020
Q1 | $35K | Sell |
|
|||||
|
2019
Q4 | $134K | Buy |
|
|||||
|
2019
Q3 | $65K | Sell |
|
|||||
|
2019
Q2 | $344K | Buy |
|
|||||
|
2019
Q1 | $60K | Buy |
|